Ubs Group Ag Global Blood Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$32.4 - $68.18 $5.45 Million - $11.5 Million
168,360 Added 155.19%
276,847 $18.9 Million
Q2 2022

Aug 10, 2022
SELL
$22.3 - $37.39 $504,381 - $845,687
-22,618 Reduced 17.25%
108,487 $3.47 Million
Q1 2022

May 16, 2022
BUY
$25.68 - $35.59 $544,416 - $754,508
21,200 Added 19.29%
131,105 $4.54 Million
Q4 2021

Feb 14, 2022
SELL
$24.9 - $40.26 $893,287 - $1.44 Million
-35,875 Reduced 24.61%
109,905 $3.22 Million
Q3 2021

Nov 15, 2021
BUY
$25.48 - $37.34 $2.24 Million - $3.28 Million
87,820 Added 151.52%
145,780 $3.72 Million
Q2 2021

Aug 13, 2021
SELL
$32.46 - $43.42 $752,130 - $1.01 Million
-23,171 Reduced 28.56%
57,960 $2.03 Million
Q1 2021

May 12, 2021
BUY
$38.94 - $50.85 $2.78 Million - $3.63 Million
71,410 Added 734.6%
81,131 $3.31 Million
Q4 2020

Feb 11, 2021
BUY
$37.65 - $63.77 $273,188 - $462,715
7,256 Added 294.36%
9,721 $421,000
Q3 2020

Nov 12, 2020
SELL
$52.76 - $74.49 $159,757 - $225,555
-3,028 Reduced 55.12%
2,465 $136,000
Q2 2020

Jul 31, 2020
SELL
$48.73 - $81.82 $299,299 - $502,538
-6,142 Reduced 52.79%
5,493 $347,000
Q1 2020

May 01, 2020
SELL
$41.72 - $87.2 $263,461 - $550,668
-6,315 Reduced 35.18%
11,635 $594,000
Q4 2019

Feb 14, 2020
SELL
$45.7 - $81.86 $4.74 Million - $8.5 Million
-103,815 Reduced 85.26%
17,950 $1.43 Million
Q3 2019

Nov 14, 2019
BUY
$45.35 - $57.91 $2.29 Million - $2.92 Million
50,507 Added 70.88%
121,765 $5.91 Million
Q2 2019

Aug 14, 2019
BUY
$52.6 - $63.29 $2.5 Million - $3 Million
47,444 Added 199.23%
71,258 $3.75 Million
Q1 2019

May 14, 2019
SELL
$39.99 - $53.48 $4.76 Million - $6.37 Million
-119,066 Reduced 83.33%
23,814 $1.26 Million
Q4 2018

Feb 14, 2019
BUY
$31.54 - $46.67 $2.07 Million - $3.07 Million
65,783 Added 85.32%
142,880 $5.87 Million
Q3 2018

Nov 14, 2018
BUY
$38.0 - $51.1 $261,782 - $352,027
6,889 Added 9.81%
77,097 $2.93 Million
Q2 2018

Aug 14, 2018
SELL
$38.7 - $50.15 $2.56 Million - $3.32 Million
-66,186 Reduced 48.53%
70,208 $3.17 Million
Q1 2018

May 15, 2018
BUY
$39.6 - $65.9 $4.05 Million - $6.74 Million
102,351 Added 300.65%
136,394 $6.59 Million
Q4 2017

Feb 14, 2018
SELL
$29.7 - $45.7 $1.13 Million - $1.74 Million
-38,127 Reduced 52.83%
34,043 $1.34 Million
Q3 2017

Nov 14, 2017
BUY
$25.1 - $31.05 $171,357 - $211,978
6,827 Added 10.45%
72,170 $2.24 Million
Q2 2017

Aug 14, 2017
BUY
N/A
28,120 Added 75.54%
65,343 $1.79 Million
Q1 2017

Nov 14, 2017
BUY
N/A
37,223
37,223 $1.37 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email